CDC40 suppression induces CDCA5 splicing defects and anti-proliferative effects in lung cancer cells

Abstract High mortality and low response rates in lung cancer patients call for novel therapeutic targets. Data mining of whole-genome genetic dependency screens suggest Cell Division Cycle 40 (CDC40) to be an essential protein for lung cancer cell survival. We characterized CDC40 knockdown effects...

Full description

Saved in:
Bibliographic Details
Main Authors: Die Hu, Brigitte L. Thériault, Vida Talebian, Laurent Hoffer, Julie Owen, Justin Lim, Benjamin J. Blencowe, Evelyne Lima-Fernandes, Punit Saraon, Richard Marcellus, Rima Al-awar
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-024-83337-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841559640882544640
author Die Hu
Brigitte L. Thériault
Vida Talebian
Laurent Hoffer
Julie Owen
Justin Lim
Benjamin J. Blencowe
Evelyne Lima-Fernandes
Punit Saraon
Richard Marcellus
Rima Al-awar
author_facet Die Hu
Brigitte L. Thériault
Vida Talebian
Laurent Hoffer
Julie Owen
Justin Lim
Benjamin J. Blencowe
Evelyne Lima-Fernandes
Punit Saraon
Richard Marcellus
Rima Al-awar
author_sort Die Hu
collection DOAJ
description Abstract High mortality and low response rates in lung cancer patients call for novel therapeutic targets. Data mining of whole-genome genetic dependency screens suggest Cell Division Cycle 40 (CDC40) to be an essential protein for lung cancer cell survival. We characterized CDC40 knockdown effects in multiple lung cancer cell lines, revealing induced cell cycle defects that resulted in strong growth inhibition and activation of apoptosis. Global transcriptional and splicing changes were also investigated, where CDC40 knockdown resulted in perturbation of splicing- and translation-related genes as well as more transcripts with intron retention. In the transcript of the cell cycle regulatory protein CDCA5, CDC40 knockdown was shown to induce retention of the first intron, leading to an increase in the unspliced CDCA5 transcript and subsequent decrease in CDCA5 protein expression. Additionally, protein–protein interactions of CDC40 were explored and spliceosome components were found to be its main binding partners, further highlighting the role of CDC40 in splicing. CDC40 mutation analysis suggests that it may be difficult to disrupt key interactions using small molecules within a large complex. Our results demonstrate that CDC40 is essential for lung cancer cell growth, and that its inhibition may represent a viable therapeutic strategy for lung cancer.
format Article
id doaj-art-1a213078b1814ee69ef54ce2f2935dab
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-1a213078b1814ee69ef54ce2f2935dab2025-01-05T12:19:17ZengNature PortfolioScientific Reports2045-23222025-01-0115111510.1038/s41598-024-83337-zCDC40 suppression induces CDCA5 splicing defects and anti-proliferative effects in lung cancer cellsDie Hu0Brigitte L. Thériault1Vida Talebian2Laurent Hoffer3Julie Owen4Justin Lim5Benjamin J. Blencowe6Evelyne Lima-Fernandes7Punit Saraon8Richard Marcellus9Rima Al-awar10Drug Discovery Program, Ontario Institute for Cancer ResearchDrug Discovery Program, Ontario Institute for Cancer ResearchDrug Discovery Program, Ontario Institute for Cancer ResearchDrug Discovery Program, Ontario Institute for Cancer ResearchDrug Discovery Program, Ontario Institute for Cancer ResearchDonnelly Centre for Cellular and Biomolecular Research, University of TorontoDonnelly Centre for Cellular and Biomolecular Research, University of TorontoDrug Discovery Program, Ontario Institute for Cancer ResearchDrug Discovery Program, Ontario Institute for Cancer ResearchDrug Discovery Program, Ontario Institute for Cancer ResearchDrug Discovery Program, Ontario Institute for Cancer ResearchAbstract High mortality and low response rates in lung cancer patients call for novel therapeutic targets. Data mining of whole-genome genetic dependency screens suggest Cell Division Cycle 40 (CDC40) to be an essential protein for lung cancer cell survival. We characterized CDC40 knockdown effects in multiple lung cancer cell lines, revealing induced cell cycle defects that resulted in strong growth inhibition and activation of apoptosis. Global transcriptional and splicing changes were also investigated, where CDC40 knockdown resulted in perturbation of splicing- and translation-related genes as well as more transcripts with intron retention. In the transcript of the cell cycle regulatory protein CDCA5, CDC40 knockdown was shown to induce retention of the first intron, leading to an increase in the unspliced CDCA5 transcript and subsequent decrease in CDCA5 protein expression. Additionally, protein–protein interactions of CDC40 were explored and spliceosome components were found to be its main binding partners, further highlighting the role of CDC40 in splicing. CDC40 mutation analysis suggests that it may be difficult to disrupt key interactions using small molecules within a large complex. Our results demonstrate that CDC40 is essential for lung cancer cell growth, and that its inhibition may represent a viable therapeutic strategy for lung cancer.https://doi.org/10.1038/s41598-024-83337-z
spellingShingle Die Hu
Brigitte L. Thériault
Vida Talebian
Laurent Hoffer
Julie Owen
Justin Lim
Benjamin J. Blencowe
Evelyne Lima-Fernandes
Punit Saraon
Richard Marcellus
Rima Al-awar
CDC40 suppression induces CDCA5 splicing defects and anti-proliferative effects in lung cancer cells
Scientific Reports
title CDC40 suppression induces CDCA5 splicing defects and anti-proliferative effects in lung cancer cells
title_full CDC40 suppression induces CDCA5 splicing defects and anti-proliferative effects in lung cancer cells
title_fullStr CDC40 suppression induces CDCA5 splicing defects and anti-proliferative effects in lung cancer cells
title_full_unstemmed CDC40 suppression induces CDCA5 splicing defects and anti-proliferative effects in lung cancer cells
title_short CDC40 suppression induces CDCA5 splicing defects and anti-proliferative effects in lung cancer cells
title_sort cdc40 suppression induces cdca5 splicing defects and anti proliferative effects in lung cancer cells
url https://doi.org/10.1038/s41598-024-83337-z
work_keys_str_mv AT diehu cdc40suppressioninducescdca5splicingdefectsandantiproliferativeeffectsinlungcancercells
AT brigitteltheriault cdc40suppressioninducescdca5splicingdefectsandantiproliferativeeffectsinlungcancercells
AT vidatalebian cdc40suppressioninducescdca5splicingdefectsandantiproliferativeeffectsinlungcancercells
AT laurenthoffer cdc40suppressioninducescdca5splicingdefectsandantiproliferativeeffectsinlungcancercells
AT julieowen cdc40suppressioninducescdca5splicingdefectsandantiproliferativeeffectsinlungcancercells
AT justinlim cdc40suppressioninducescdca5splicingdefectsandantiproliferativeeffectsinlungcancercells
AT benjaminjblencowe cdc40suppressioninducescdca5splicingdefectsandantiproliferativeeffectsinlungcancercells
AT evelynelimafernandes cdc40suppressioninducescdca5splicingdefectsandantiproliferativeeffectsinlungcancercells
AT punitsaraon cdc40suppressioninducescdca5splicingdefectsandantiproliferativeeffectsinlungcancercells
AT richardmarcellus cdc40suppressioninducescdca5splicingdefectsandantiproliferativeeffectsinlungcancercells
AT rimaalawar cdc40suppressioninducescdca5splicingdefectsandantiproliferativeeffectsinlungcancercells